Ribophorin II (RPN2) is a protein component of an N-oligosaccharyl transferase complex, the downregulation of which can trigger apoptosis in human breast cancer cells resistant to docetaxel., and its silencing confers sensitivity of the tumor to cisplatin treatment (Honma et al., 2008). The gene discussed is RPN2; the disease is breast carcinoma.